Multimodal Laser Treatment of Photodamaged Skin
NCT: NCT07789002 · NOT_YET_RECRUITING
Brief Summary
The Multimodal Laser Project is a prospective, randomized, split-face clinical study investigating a novel combination of laser and light-based treatments for facial photodamage with the long-term perspective of improving skin cancer prevention. The study includes 35 patients with facial photodamage and AKs. One side of the face receives a multimodal treatment combining three complementary technologies: 1927-nm thulium laser, 1550-nm non-ablative fractional laser, and intense pulsed light (IPL), while the contralateral side serves as an untreated control. Participants are followed for 14 months to assess both clinical efficacy and longer-term preventive effects. The overall aim is not only to determine whether multimodal laser treatment improves photodamaged skin, but also to gain a deeper understanding of how the treatment affects the underlying biology of chronically sun-damaged skin and its potential role in skin cancer prevention.
Frequently Asked Questions
What is Multimodal Laser Treatment of Photodamaged Skin?
Multimodal Laser Treatment of Photodamaged Skin is a clinical trial registered under NCT07789002. Current status: NOT_YET_RECRUITING.
What is the status of NCT07789002?
The current status of NCT07789002 (Multimodal Laser Treatment of Photodamaged Skin) is: NOT_YET_RECRUITING.
When did Multimodal Laser Treatment of Photodamaged Skin start?
Multimodal Laser Treatment of Photodamaged Skin started on 2026-09-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.